Platelet-rich plasma and skeletal muscle healing: A molecular analysis of the early phases of the regeneration process in an experimental animal model

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Dimauro, Ivan ^a   Grasso, Loredana ^a   Fittipaldi, Simona ^a   Fantini, Cristina ^a   Mercatelli, Neri ^a   Racca, Silvia ^b   Geuna, Stefano ^b   Gianfrancesco, Alessia Di ^a   Caporossi, Daniela ^a   Pigozzi, Fabio ^a   Borrione, Paolo ^a  

^a UNIVERSITY OF ROME FORO ITALICO   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CRYSTALLIN; CASPASE 3; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 70; INTERLEUKIN 10; INTERLEUKIN 1BETA; MESSENGER RNA; MICRORNA; MICRORNA 1; MICRORNA 133A; MICRORNA 206; MRF4 PROTEIN; MYOD1 PROTEIN; MYOGENIC FACTOR; MYOGENIC FACTOR 5; MYOGENIN; PROTEIN BAX; PROTEIN BCL 2; SERUM RESPONSE FACTOR; SOMATOMEDIN C; TRANSCRIPTION FACTOR PAX7; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; FLEXOR SUBLIMIS MUSCLE; GENE EXPRESSION; MALE; MUSCLE INJURY; MUSCLE REGENERATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; RAT; SKELETAL MUSCLE; THROMBOCYTE RICH PLASMA; ANIMAL; DRUG EFFECTS; INJURIES; METABOLISM; PHYSIOLOGY; REGENERATION; WISTAR RAT; WOUND HEALING;

ANIMALS; INTERLEUKIN-1BETA; MALE; MODELS, ANIMAL; MUSCLE, SKELETAL; PLATELET-RICH PLASMA; RATS; RATS, WISTAR; REGENERATION; TRANSFORMING GROWTH FACTOR BETA1; WOUND HEALING;

EID: 84904690270     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0102993     Document Type: Article

References (100)

1. Woolf AD, Pfleyer B (2003) Burden of major musculoskeletal conditions. Bull World Health Organ 81: 646-56. (Pubitemid 37254686)
2. Marx RE (2004) Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 62: 489-496.
3. Wright-Carpenter T, Opolon P, Appell HJ, Meijer H, et al. (2004) Treatment of muscle injuries by local administration of autologous conditioned serum: animal experiments using a muscle contusion model. Int J Sports Med 25: 582-587. (Pubitemid 39518135)
4. Cervelli V, Gentile P, Scioli MG, Grimaldi M, Casciani CU, et al. (2009) Application of platelet-rich plasma in plastic surgery: clinical and in vitro evaluation. Tissue Eng Part C Methods 15: 625-634.
5. Kazakos K, Lyras DN, Verettas D, Tilkeridis K, Tryfonidis M (2009) The use of autologous PRP gel as an aid in the management of acute trauma wounds. Injury 40: 801-805.
6. Hammond JW, Hinton RY, Curl LA, Muriel JM, Lovering RM (2009) Use of autologous platelet-rich plasma to treat muscle strain injuries. Am J Sports Med 37: 1135-42.
7. Borrione P, Grasso L, Chierto E, Geuna S, Racca S, et al. (2013) Experimental model for the study of the effects of platelet-rich plasma on the early phases of muscle healing. Blood Transfus 19: 1-8.
8. Kaux JF, Crielaard JM (2013) Platelet-rich plasma application in the management of chronic tendinopathies. Acta Orthop Belg 79: 10-5.
9. Ehrenfest D, Rasmusson L, Albrektsson T (2009) Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF). Trends Biotechnol 27: 158-167.
10. Ferrari M, Zia S, Valbonesi M, Henriquet F, Venere G, et al. (1987) A new technique for hemodilution, preparation of autologous platelet-rich plasma and intraoperative blood salvage in cardiac-surgery. Int J Artificial Organs 10: 47-50. (Pubitemid 17028923)
11. Knighton DR, Doucette M, Fiegel VD, Ciresi K, Butler E, et al. (1988) The use of platelet derived wound healing formula in human clinical trials. Prog Clin Biol Res 266: 319-329.
12. Marx RE (2001) Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dentistry 10: 225-228.
13. Menetrey J, Kasemkijwattana C, Day CS, Bosch P, Vogt M, et al. (2000) Growth factors improve muscle healing in vivo. J Bone Joint Surg Br 82: 131-137. (Pubitemid 30060141)
14. Kaux JF, Drion PV, Colige A, Pascon F, Libertiaux V, et al. (2012) Effects of platelet-rich plasma (PRP) on the healing of Achilles tendons of rats. Wound Repair Regen 20: 748-56.
15. DeLong JM, Russell RP, Mazzocca AD (2012) Platelet-rich plasma: the PAW classification system. Arthroscopy 28: 998-1009.
16. Charge SB, Rudnicki MA (2004) Cellular and molecular regulation of muscle regeneration. Physiol Rev 84: 209-238. (Pubitemid 38049880)
17. Lefaucheur JP, Sebille A (1995) The cellular events of injured muscle regeneration depend on the nature of the injury. Neuromuscul Disord 5: 501-509.
18. Fink E, Fortin D, Serrurier B, Ventura-Clapier R, et al. (2003) Recovery of contractile and metabolic phenotypes in regenerating slow muscle after notexin-induced or crush injury. J Muscle Res Cell Motil 24: 421-429. (Pubitemid 37475986)
19. Collins RA, Grounds MD (2001) The role of tumor necrosis factor-alpha (TNF-alpha) in skeletal muscle regeneration. Studies in TNF-alpha(-/-) and TNF-alpha (-/-)/LT-alpha (-/-) mice. J Histochem Cytochem 49: 989-1001. (Pubitemid 32675006)
20. Warren GL, Hulderman T, Jensen N, McKinstry M, Mishra M, et al. (2002) Physiological role of tumor necrosis factor alpha in traumatic muscle injury. FASEB J 16: 1630-1632.
21. Gadient RA, Patterson PH (1999) Leukemia inhibitory factor, Interleukin 6, and other cytokines using the GP130 transducing receptor: roles in inflammation and injury. Stem Cells 17: 127-137. (Pubitemid 29226663)
22. Villalta SA, Rinaldi C, Deng B, Liu G, Fedor B, et al. (2011) Interleukin-10 reduces the pathology of mdx muscular dystrophy by deactivating M1 macrophages and modulating macrophage phenotype. Hum Mol Genet 20: 790-805.
23. Border WA, Noble NA (1994) Transforming growth factor beta in tissue fibrosis. N Engl J Med 331: 1286-1292. (Pubitemid 24333194)
24. Massague J, Cheifetz S, Endo T, Nadal-Ginard B (1986) Type beta transforming growth factor is an inhibitor of myogenic differentiation. Proc Natl Acad Sci USA 83: 8206-8210. (Pubitemid 17182470)
25. Li Y, Cummins J, Huard J (2001) Muscle injury and repair. Curr Opin Orthopaed 12: 409-415. (Pubitemid 32917767)
26. Chan YS, Li Y, Foster W, Fu FH, Huard J (2005) The use of suramin, an antifibrotic agent to improve muscle recovery after strain injury. Am J Sports Med 33: 43-51. (Pubitemid 40039558)
27. McLennan IS, Koishi K (2002) The transforming growth factor-betas: multifaceted regulators of the development and maintenance of skeletal muscles, motoneurons and Schwann cells. Int J DevBiol 46: 559-567. (Pubitemid 36841025)
28. Florini JR, Ewton DZ, Coolican SA (1996) Growth hormone and the insulinlike growth factor system in myogenesis. Endocr Rev 17: 481-517. (Pubitemid 26346639)
29. Parise G, O'Reilly CE, Rudnicki MA (2006) Molecular regulation of myogenic progenitor populations. Appl Physiol Nutr Metab 31: 773-781.
30. Sabourin LA, Rudnicki MA (2000) The molecular regulation of myogenesis. Clin Genet 57: 16-25. (Pubitemid 30105556)
31. Pavlath GK, Dominov JA, Kegley KM, Miller JB (2003) Regeneration of transgenic skeletal muscles with altered timing of expression of the basic helix-loop-helix muscle regulatory factor MRF4. Am J Pathol 162: 1685-1691. (Pubitemid 36512852)
32. Dellavalle A, Sampaolesi M, Tonlorenzi R, Tagliafico E, Sacchetti B, et al. (2007) Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat Cell Biol 9: 255-267. (Pubitemid 46349927)
33. Musarò A, Giacinti C, Borsellino G, Dobrowolny G, Pelosi L, et al. (2004) Stem cell-mediated muscle regeneration is enhanced by local isoform of insulin-like growth factor 1. Proc Natl Acad Sci USA 101: 1206-1210. (Pubitemid 38182667)
34. Pelosi L, Giacinti C, Nardis C, Borsellino G, Rizzuto E, et al. (2007) Local expression of IGF-1 accelerates muscle regeneration by rapidly modulating inflammatory cytokines and chemokines. FASEB J 21: 1393-402. (Pubitemid 46684842)
35. Matheny RW Jr, Nindl BC, Adamo ML (2010) Minireview: Mechano-growth factor: a putative product of IGF-I gene expression involved in tissue repair and regeneration. Endocrinology 151: 865-75.
36. Philippou A, Papageorgiou E, Bogdanis G, Halapas A, Sourla A, et al. (2009) Expression of IGF-1 isoforms after exercise-induced muscle damage in humans: characterization of the MGF E peptide actions in vitro. In Vivo 23: 567-575.
37. Stavropoulou A, Halapas A, Sourla A, Philippou A, Papageorgiou E, et al. (2009) IGF-1 expression in infarcted myocardium and MGF E peptide actions in rat cardiomyocytes in vitro. Mol Med 15: 127-135.
38. McCarthy JJ (2008) MicroRNA-206: The skeletal muscle-specific myomiR. Biochim Biophys Acta 1779: 682-691.
39. Thomson JM, Parker J, Perou CM, Hammond SM (2004) A custom microarray platform for analysis of microRNA gene expression. Nat Methods 1: 47-53.
40. Chen JF, Mandel EM, Thomson JM,Wu Q, Callis TE, et al. (2006) The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 38: 228-33. (Pubitemid 43177239)
41. Rosenberg MI, Georges SA, Asawachaicharn A, Analau E, Tapscott SJ (2006) MyoD inhibits Fstl1 and Utrn expression by inducing transcription of miR-206. J Cell Biol 175: 77-85. (Pubitemid 44537200)
42. Anderson C, Catoe H, Werner R (2006) MIR-206 regulates connexin43 expression during skeletal muscle development. Nucleic Acids Res 34: 5863-5871. (Pubitemid 44941165)
43. Kim HK, Lee YS, Sivaprasad U, Malhotra A, Dutta A (2006) Muscle-specific microRNA miR-206 promotes muscle differentiation. J Cell Biol 174: 677-687. (Pubitemid 44306724)
44. McCarthy JJ, Esser KA (2007a) MicroRNA-1 and microRNA-133a expression are decreased during skeletal muscle hypertrophy. J Appl Physiol 102: 306-313. (Pubitemid 46089780)
45. McCarthy JJ, Esser KA, Andrade FH (2007b) MicroRNA-206 is overexpressed in the diaphragm but not the hindlimb muscle of mdx mouse. Am J Physiol Cell Physiol 293: C451-457. (Pubitemid 47105025)
46. Care A, Catalucci D, Felicetti F, Bonci D, Addario A, et al. (2007) MicroRNA-133 controls cardiac hypertrophy. Nat Med 13: 613-618. (Pubitemid 46828487)
47. Zhang D, Li X, Chen C, Li Y, Zhao L, et al. (2012) Attenuation of p38-mediated miR-1/133 expression facilitates myoblast proliferation during the early stage of muscle regeneration. PLoS One 7:e41478.
48. Yuasa K, Hagiwara Y, Ando M, Nakamura A, Takeda S, et al. (2008) MicroRNA-206 is highly expressed in newly formed muscle fibers: implications regarding potential for muscle regeneration and maturation in muscular dystrophy. Cell Structure and function 33: 163-9.
49. Nakasa T, Ishikawa M, Shi M, Shibuya H, Adachi N, et al. (2010) Acceleration of muscle regeneration by local injection of muscle-specific microRNAs in rat skeletal muscle injury model. J Cell Mol Med. 14: 2495-505.
50. Chen JF, Tao Y, Li J, Deng Z, Yan Z, et al. (2010) microRNA-1 andmicroRNA-206 regulate skeletal muscle satellite cell proliferation and differentiation by repressing Pax7. J Cell Biol 190: 867-879.
51. Milano JM (2003) Serum response factor: toggling between disparate programs of gene expression. J Mol Cell Cardiol 35: 577-93.
52. Zhao Y, Samal E, Strivastava D (2005) Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 436: 214-20. (Pubitemid 41021266)
53. Pipes GC, Creemers EE, Olson EN. (2006) The myocardin family of transcriptional co-activators: versatile regulators of cell growth, migration, and myogenesis. Genes Dev 20: 1545-1556. (Pubitemid 43901093)
54. Soulez M, Rouviere CG, Chafey P, Hentzen D, Vandromme M, et al. (1996) Growth and differentiation of C2 myogenic cells are dependent on serum response factor. Mol Cell Biol 16: 6065-6074. (Pubitemid 26360966)
55. Keren A, Tamir Y, Bengal E (2006) The p38 MAPK signaling pathway: a major regulator of skeletal muscle development. Mol Cell Endocrinol 252: 224-230.
56. Lluis F, Perdiguero E, Nebreda AR, Munoz-Canoves P (2006) Regulation of skeletal muscle gene expression by p38 MAP kinases. Trends Cell Biol 16: 36-44. (Pubitemid 43077093)
57. Liao P, Georgakopoulos D, Kovacs A, Zheng M, Lerner D, et al. (2001) The in vivo role of p38 MAP kinases in cardiac remodeling and restrictive cardiomyopathy. Proc Natl Acad Sci USA 98: 12283-12288. (Pubitemid 32959865)
58. Richard-Bulteau H, Serrurier B, Crassous B, Banzet S, et al. (2008) Recovery of skeletal muscle mass after extensive injury: positive effects of increased contractile activity. Am J Physiol Cell Physiol 294: C467-76. (Pubitemid 351264411)
59. Haynes JI 2nd, Duncan MK, Piatigorsky J (1996) Spatial and temporal activity of the alpha B-crystallin/small heat shock protein gene promoter in transgenic mice. Dev Dyn 207: 75-88. (Pubitemid 26299051)
60. Sugiyama Y, Suzuki A, Kishikawa M, Akutsu R, Hirose T, et al. (2000) Muscle develops a specific form of small heat shock protein complex composed of MKBP/HSPB2 and HSPB3 during myogenic differentiation. J Biol Chem 275: 1095-104. (Pubitemid 30051159)
61. Benjamin IJ, Shelton J, Garry DJ, Richardson JA (1997) Temporospatial expression of the small HSP/alpha B-crystallin in cardiac and skeletal muscle during mouse development. Dev Dyn 208: 75-84. (Pubitemid 27030485)
62. Lavoie JN, Hickey E, Weber LA, Landry J (1993) Modulation of actin microfilament dynamics and fluid phase pinocytosis by phosphorylation of heat shock protein. J Biol Chem 268: 24210-24214. (Pubitemid 23335406)
63. Benndorf R, Hayess K, Ryazantsev S, Wieske M, Behlke J, et al. (1994) Phosphorylation and supramolecular organization of murine small heat shock protein HSP25 abolish its actin polymerization-inhibiting activity. J Biol Chem 269: 20780-20784. (Pubitemid 24260495)
64. Wang J, Walsh K (1996) Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. Science 273: 359-361. (Pubitemid 26250264)
65. Mehlen P, Kretz-Remy C, Pre ville X, Arrigo AP (1996) Human hsp27, Drosophila hsp27 and human aB-crystallin expression-mediated increase in glutathione is essential for the protective activity of these proteins against TNF-α induced cell death. EMBO J 15: 2695-2706. (Pubitemid 26176247)
66. Davidson SM, Morange M (2000) Hsp25 and the p38 MAPK pathway are involved in differentiation of cardiomyocytes. Dev Biol 218: 146-160. (Pubitemid 30101965)
67. Kamradt MC, Chen F, Sam S, Cryns VL (2002) The small heat shock protein AlphaB- crystallin negatively regulates apoptosis during myogenic differentiation by inhibiting caspase-3 activation. J Biol Chem 277: 38731-38736.
68. denEngelsman J, Gerrits D, de Jong WW, Robbins J, Kato K, et al. (2005) Nuclear import of aB-crystallin is phosphorylation-dependent and hampered by hyperphosphorylation of the myopathy-related mutant R120G. J Biol Chem 280: 37139-37148.
69. Kato K, Ito H, Kamei K, Inaguma Y, Iwamoto I, et al. (1998) Phosphorylation of alphaB-crystallin in mitotic cells and identification of enzymatic activities responsible for phosphorylation. J Biol Chem 273: 28346-28354. (Pubitemid 28496136)
70. Kostenko S, Moens U (2009) Heat shock protein 27 phosphorylation: kinases, phosphatases, functions and pathology. Cell Mol Life Sci 66: 3289-307.
71. Perkins ND, Gilmore TD (2006) Good cop, bad cop: the different faces of NF-kappaB. Cell Death Differ 13: 759-72.
72. Karin M, Lin A (2002) NF-kappaB at the crossroads of life and death. Nat Immunol 3: 221-7.
73. Ito H, Kamei K, Iwamoto I, Inaguma Y, Kato K (2001) Regulation of the levels of small heat-shock proteins during differentiation of C2C12 cells. Exp Cell Res 266: 213-21. (Pubitemid 32579226)
74. Senf SM, Howard TM, Ahn B, Ferreira LF, Judge AR (2013) Loss of the inducible Hsp70 delays the inflammatory response to skeletal muscle injury and severely impairs muscle regeneration. PLoS One 8: e62687.
75. Yan Z, Choi S, Liu X, Zhang M, Schageman JJ, et al. (2003) Highly coordinated gene regulation in mouse skeletal muscle regeneration. J Biol Chem 278: 8826-8836. (Pubitemid 36800642)
76. Webster KA (2003) Serine phosphorylation and suppression of apoptosis by the small heat shock protein alphaB-crystallin. Circ Res 92: 130-2.
77. Adhikari AS, Singh BN, Rao KS, Rao ChM (2001) αB-crystallin, a small heat shock protein, modulates NF-κB activity in a phosphorylation-dependent manner and protects muscle myoblasts from TNF-α induced cytotoxicity. Biochim Biophys Acta 1813: 1532-42.
78. Wright-Carpenter T, Klein P, Schaferhoff P, Appell HJ, et al. (2004a) Treatment of muscle injuries by local administration of autologous conditioned serum: A pilot study on sportsmen with muscle strains. Int J Sports Med.25: 588-593. (Pubitemid 39518136)
79. Wright-Carpenter T, Opolon P, Appell HJ, Meijer H, et al. (2004b) Treatment of muscle injuries by local administration of autologous conditioned serum: Animal experiments using a muscle contusion model. Int J Sports Med 25: 582-587. (Pubitemid 39518135)
80. Espregueira-Mendes J, Arce C. Referee lesions. In: Volpi P, ed. Football Traumatology: Current Concepts: From Prevention toTreatment. Milan, Italy: Springer 2006:92.
81. Mishra A, Pavelko T (2006) Treatment of chronic elbow tendinosis with buffered platelet-rich plasma. Am J Sports Med. 34: 1774-1778. (Pubitemid 44735517)
82. Virchenko O, Aspenberg P (2006) How can one platelet injection after tendon injury lead to a stronger tendon after 4 weeks? Interplay between early regeneration and mechanical stimulation. Acta Orthop 77: 806-12. (Pubitemid 44521924)
83. Randelli PS, Arrigoni P, Cabitza P, Volpi P, Maffulli N (2008) Autologous platelet rich plasma for arthroscopic rotator cuff repair: a pilot study. Disabil Rehabil 30: 1584-1589.
84. Sánchez M, Anitua E, Azofra J, Andía I, Padilla S, et al. (2007) Comparison of surgically repaired Achilles tendon tears using platelet-rich fibrin matrices. Am J Sports Med 35: 245-51.
85. de Vos RJ, Weir A, van Schie HT, Bierma-Zeinstra SM, Verhaar JA, et al. (2010) Platelet-rich plasma injection for chronic Achilles tendinopathy: a randomized controlled trial. JAMA 303: 144-49.
86. Edwards S, Caladruccio J (2003) Autologous blood injections for refractory lateral epicondylitis. J Hand Surg Am 28: 272-278. (Pubitemid 36373325)
87. Orrego M, Larrain C, Rosales J, Valenzuela L, Matas J, et al. (2008) Effects of platelet concentrate and a bone plug on the healing of hamstring tendon in a bone tunnel. Arthroscopy 24: 1373-1380.
88. Kon E, Filardo G, Delcogliano M, Presti ML, Russo A, et al. (2009) Platelet-rich plasma: new clinical application. A pilot study for treatment of jumper's knee. Injury 40: 598-603.
89. Wang-Saegusa A, Cugat R, Ares O, Seijas R, et al. (2010) Infiltration of plasma rich in growth factors for osteoarthritis of the knee short-term effects on function and quality of life. Archiv Orthop Traum Surg 131: 311-7.
90. Kon E, Buda R, Filardo G, Di Martino A, Timoncini A, et al. (2010) Platelet-rich plasma: intra-articular knee injections produced favorable results on degenerative cartilage lesions. Knee Surg Sports Traumatol Arthrosc. 18: 472-9.
91. Filardo G, Kon E, Buda R, Timoncini A, Di Martino A, et al. (2011) Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis. Knee Surg Sports Traumatol Arthrosc 19: 528-35.
92. Loo W, Lee D, Soon M (2009) Plasma rich in growth factors to treat adductor longus tear. Ann Acad Med 38: 733-734.
93. Askling C, Saartok T, Thorstensson A. (2006) Type of acute hamstring strain affects flexibility, strength, and time to return to pre-injury level. Br J Sports Med 40: 40-44. (Pubitemid 43028590)
94. Smets F, Croisier JL, Forthomme B, Crielaard JM, Kaux JF (2012) Clinical applications of platelet-rich plasma (PRP) in tendon lesions: A literature review. Science & Sports 27: 141-153.
95. Sampson S, Gerhardt M, Mandelbaum B (2008) Platelet rich plasma injection grafts for musculoskeletal injuries: a review. Curr Rev Musculoskelet Med 1: 165-74.
96. Kaux JF, Croisier JL, Léonard P, Le Goff C, Crielaard JM (2014) Exuberant inflammatory reaction as a side effect of platelet-rich plasma injection in treating one case of tendinopathy. Clin J Sport Med 24: 150-2.
97. Kon E, Filardo G, Di Martino A, Marcacci M (2011) Platelet-rich plasma (PRP) to treat sports injuries: evidence to support its use. Knee Surg Sports Traumatol Arthrosc 19: 516-27.
98. Aspenberg P, Virchenko O (2004) Platelet concentrate injection improves Achilles tendon repair in rats. Acta Orthopaed Scand 75: 93-9. (Pubitemid 38264933)
99. Asfaha S, Cenac N, Houle S, Altier C, Papez MD, et al. (2007) Protease-activated receptor-4: a novel mechanism of inflammatory pain modulation. Br J Pharmacol 50: 176-85. (Pubitemid 46160607)
100. Khan KM, Scott A (2009) Mechanotherapy: how physical therapists' prescription of exercise promotes tissue repair. Br J Sports Med 43: 247-52.